Koers Henan Taloph Pharmaceutical Stock Co.,Ltd
Aandelen
600222
CNE0000010L8
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,97 CNY | +4,63% | -8,64% | -18,92% |
Omzet 2022 | 1,96 mld. 271 mln. 254 mln. | Omzet 2023 | 2,07 mld. 286 mln. 268 mln. | Marktkapitalisatie | 3,43 mld. 474 mln. 445 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -72 mln. -9,95 mln. -9,34 mln. | Nettowinst (verlies) 2023 | 43 mln. 5,94 mln. 5,58 mln. | EV/omzet 2022 | 1,95 x |
Nettoschuld 2022 | 280 mln. 38,63 mln. 36,26 mln. | Nettoschuld 2023 | 430 mln. 59,42 mln. 55,77 mln. | EV/omzet 2023 | 1,86 x |
K/w-verhouding 2022 |
-49,6
x | K/w-verhouding 2023 |
79,2
x | Werknemers | 2.353 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 69,53% |
1 dag | +4,63% | ||
1 week | -8,64% | ||
Lopende maand | -5,87% | ||
1 maand | -4,24% | ||
3 maanden | -12,50% | ||
6 maanden | -13,57% | ||
Lopend jaar | -18,92% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jing Liang Li
CEO | Chief Executive Officer | 55 | 31-08-07 |
Hai Lin Zhao
DFI | Director of Finance/CFO | 49 | - |
Jian Chao Luo
BRD | Director/Board Member | 51 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jing Liang Li
CEO | Chief Executive Officer | 55 | 31-08-07 |
Xiao Hua Yin
BRD | Director/Board Member | 71 | 09-09-19 |
Zhi Xian Zhang
CHM | Chairman | 51 | 15-11-11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 4,97 | +4,63% | 31 412 240 |
16-04-24 | 4,75 | -10,04% | 36 471 040 |
15-04-24 | 5,28 | -6,71% | 34 946 150 |
12-04-24 | 5,66 | +1,25% | 41 317 980 |
11-04-24 | 5,59 | +2,76% | 51 287 770 |
slotkoers Shanghai S.E., 17 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-18,92% | 384 mln. | |
+28,55% | 676 mld. | |
+23,58% | 554 mld. | |
-7,11% | 349 mld. | |
+14,64% | 318 mld. | |
+7,95% | 291 mld. | |
+3,00% | 210 mld. | |
-0,46% | 204 mld. | |
-10,10% | 194 mld. | |
-11,76% | 144 mld. |